Table of Contents
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1.Lipid Nanoparticle Raw Materials Market, by Region, 2020-2030 (USD Million)
1.2.2.Lipid Nanoparticle Raw Materials Market, by Product, 2020-2030 (USD Million)
1.2.3.Lipid Nanoparticle Raw Materials Market, by Disease Indication, 2020-2030 (USD Million)
1.2.4.Lipid Nanoparticle Raw Materials Market, by Application, 2020-2030 (USD Million)
1.2.5.Lipid Nanoparticle Raw Materials Market, by End-use, 2020-2030 (USD Million)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Lipid Nanoparticle Raw Materials Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Lipid Nanoparticle Raw Materials Market Dynamics
3.1.Lipid Nanoparticle Raw Materials Market Impact Analysis (2020-2030)
3.1.1.Market Drivers
3.1.1.1.Increasing prevalence of chronic diseases
3.1.1.2.Rising government funding and support
3.1.2.Market Challenges
3.1.2.1.High development costs
3.1.2.2.Stringent regulations related to the approval and commercialization
3.1.3.Market Opportunities
3.1.3.1.Rise in the pharmaceutical research and development
3.1.3.2.Expanding applications in gene therapy and vaccines
Chapter 4.Global Lipid Nanoparticle Raw Materials Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
4.3.1.Political
4.3.2.Economical
4.3.3.Social
4.3.4.Technological
4.3.5.Environmental
4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion
Chapter 5.Global Lipid Nanoparticle Raw Materials Market, by Product
5.1.Market Snapshot
5.2.Global Lipid Nanoparticle Raw Materials Market by Product, Performance - Potential Analysis
5.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
5.4.1.Ionizable lipids
5.4.2.Reagents
5.4.3.Other raw materials
Chapter 6.Global Lipid Nanoparticle Raw Materials Market, by Disease Indication
6.1.Market Snapshot
6.2.Global Lipid Nanoparticle Raw Materials Market by Disease Indication, Performance - Potential Analysis
6.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by Disease Indication 2020-2030 (USD Million)
6.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
6.4.1.Cancer
6.4.2.Infectious Diseases
6.4.3.Blood Diseases
6.4.4.Others
Chapter 7.Global Lipid Nanoparticle Raw Materials Market, by Application
7.1.Market Snapshot
7.2.Global Lipid Nanoparticle Raw Materials Market by Application, Performance - Potential Analysis
7.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
7.4.1.Therapeutics
7.4.2.Research
Chapter 8.Lipid Nanoparticle Raw Materials Market, by End-use
8.1.Market Snapshot
8.2.Global Lipid Nanoparticle Raw Materials Market by End-use, Performance - Potential Analysis
8.3.Global Lipid Nanoparticle Raw Materials Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4.Lipid Nanoparticle Raw Materials Market, Sub Segment Analysis
8.4.1.Pharmaceutical & Biotechnology Companies
8.4.2.Academic & Research Institutes
8.4.3.Others
Chapter 9.Global Lipid Nanoparticle Raw Materials Market, Regional Analysis
9.1.Top Leading Countries
9.2.Top Emerging Countries
9.3.Lipid Nanoparticle Raw Materials Market, Regional Market Snapshot
9.4.North America Lipid Nanoparticle Raw Materials Market
9.4.1.U.S. Lipid Nanoparticle Raw Materials Market
9.4.1.1.Product breakdown estimates & forecasts, 2020-2030
9.4.1.2.Disease Indication breakdown estimates & forecasts, 2020-2030
9.4.1.3.Application breakdown estimates & forecasts, 2020-2030
9.4.1.4.End-use breakdown estimates & forecasts, 2020-2030
9.4.2.Canada Lipid Nanoparticle Raw Materials Market
9.5.Europe Lipid Nanoparticle Raw Materials Market Snapshot
9.5.1.U.K. Lipid Nanoparticle Raw Materials Market
9.5.2.Germany Lipid Nanoparticle Raw Materials Market
9.5.3.France Lipid Nanoparticle Raw Materials Market
9.5.4.Spain Lipid Nanoparticle Raw Materials Market
9.5.5.Italy Lipid Nanoparticle Raw Materials Market
9.5.6.Rest of Europe Lipid Nanoparticle Raw Materials Market
9.6.Asia-Pacific Lipid Nanoparticle Raw Materials Market Snapshot
9.6.1.China Lipid Nanoparticle Raw Materials Market
9.6.2.India Lipid Nanoparticle Raw Materials Market
9.6.3.Japan Lipid Nanoparticle Raw Materials Market
9.6.4.Australia Lipid Nanoparticle Raw Materials Market
9.6.5.South Korea Lipid Nanoparticle Raw Materials Market
9.6.6.Rest of Asia Pacific Lipid Nanoparticle Raw Materials Market
9.7.Latin America Lipid Nanoparticle Raw Materials Market Snapshot
9.7.1.Brazil Lipid Nanoparticle Raw Materials Market
9.7.2.Mexico Lipid Nanoparticle Raw Materials Market
9.8.Middle East & Africa Lipid Nanoparticle Raw Materials Market
9.8.1.Saudi Arabia Lipid Nanoparticle Raw Materials Market
9.8.2.South Africa Lipid Nanoparticle Raw Materials Market
9.8.3.Rest of Middle East & Africa Lipid Nanoparticle Raw Materials Market
Chapter 10.Competitive Intelligence
10.1.Key Company SWOT Analysis
10.2.Top Market Strategies
10.3.Company Profiles
10.3.1.Merck KGaA
10.3.1.1.Key Information
10.3.1.2.Overview
10.3.1.3.Financial (Subject to Data Availability)
10.3.1.4.Product Summary
10.3.1.5.Recent Developments
10.3.2.Echelon Biosciences
10.3.3.BroadPharm
10.3.4.Avanti Polar Lipids
10.3.5.Tebubio
10.3.6.CordenPharma International
10.3.7.Creative Biolabs
10.3.8.Biopharma PEG Scientific Inc.
10.3.9.NOF AMERICA CORPORATION
10.3.10.Polysciences, Inc.
Chapter 11.Research Process
11.1.Research Process
11.1.1.Data Mining
11.1.2.Analysis
11.1.3.Market Estimation
11.1.4.Validation
11.1.5.Publishing
11.2.Research Attributes
11.3.Research Assumption